Dr. Michael P. Tabibian, MD

Dr. Tabibian practices at Parham Tabibian MD Inc in Los Alamitos, California.

Dr. Tabibian's NPI, 1366470338, was assigned on June 29, 2006. Dr. Tabibian graduated from David Geffen School of Medicine at UCLA in 1993. Dr. Tabibian holds California license G80532.

Dr. Tabibian's primary practice is Parham Tabibian MD Inc, at 3801 Katella Ave, Los Alamitos, CA 90720 in Orange County. The practice phone is (562) 799-3330.

Dr. Tabibian's primary practice is Parham Tabibian MD Inc in Los Alamitos, California. Dr. Tabibian is also affiliated with UCI Health - Orange. The medical group on file is Advanced Dermatology Care of Southern California. Dmand AI also links Dr. Tabibian to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tabibian practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Tabibian's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Tabibian is board certified in dermatology by the American Board of Dermatology. Dr. Tabibian is licensed in California.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, corns and calluses and facial skin infection among the conditions Dr. Tabibian treats.

CMS data shows 34,710 Medicare services from Dr. Tabibian across 58 procedure codes in 2024, for 1,526 Medicare patients. Medicare paid $1,487,617 for them. Every service was in an office.

CMS counts 1,526 Medicare patients who saw Dr. Tabibian in 2024. The largest group is 65 to 74, with 767 patients. 75% of them have high cholesterol, and 69% have high blood pressure. 9% are also on Medicaid. Their average risk score is 1.07, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Tabibian's median patient age at 65, with 53% women.

In 2024, Dr. Tabibian wrote 803 Medicare Part D claims for 385 patients. 88% of them were for generic drugs. CMS names the drug for 584 of them, across 18 drugs with 11 or more claims each, at $62,550 in total drug cost. In 2023, CMS named 598 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Tabibian for performance year 2024, reported individually. Dr. Tabibian accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 2,399 procedures of removal of skin lesions by Dr. Tabibian, more than 98% of the clinicians it reports for that procedure.

CMS Open Payments shows 1,533 general payments to Dr. Tabibian from 53 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 82% of the total. Medimetriks Pharmaceuticals, Inc. paid the most, $6,646.

Dmand AI lists 1 award for Dr. Tabibian.

Dr. Tabibian graduated from David Geffen School of Medicine at UCLA in 1993. Dr. Tabibian is a member of AAD.

Dr. Tabibian is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.